SciSight Ecosystem
WoS ESCI Q4Scopus Q3SCImago #18,286CAS 4区Diamond OAHybrid

Clinical Diabetology

Country: Poland•WoS SCIE Quartile: Q4•Scopus SJR: 0.271•SCImago Rank: #18,286•Identifier (ISSN):2450-8187(Print)/2450-7458(Online)•Articles / Year: 53•Estimated Publication Fee (APC): Free (Diamond OA)
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q4
0.8
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
12

12 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
53articles/year
91.07% Gold OA•84% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 0.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 0.8)
🔵 Computed
20251.00đ
WoS Q4(IF: 0.7)
🔵 Computed
20241.00đ
WoS Q4(IF: 0.7)
🔵 Computed
20231.00đ
WoS Q4(IF: 0.7)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Clinical Diabetology hereinafter referred to as ‘CD’ or ′the Journal′, is a peer-reviewed, open access journal covering broad spectrum of topics in diabetology and aiming to advance the knowledge and science of this rapidly evolving field. The Journal is the official bimonthly of the Diabetes Poland (Polish Diabetes Association) and publishes review articles, original clinical and experimental investigations in the field of diabetology, case reports, letters and editorial comments . The Journal has been published in full text English since 2016.

Topics Covered (Recognized by AI)
Medicine99.1%Biology97.2%Endocrinology94.9%Diabetes mellitus94%Internal medicine92.7%Pathology58.9%Type 2 diabetes53.8%Insulin42.1%Biotechnology42.1%Chemistry34.5%Biochemistry32%Psychology30.4%Type 2 Diabetes Mellitus29.1%Surgery27.2%Genetics26.6%Disease22.8%Psychiatry22.5%Mathematics22.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,286Scopus Q3Diamond OASCImago Profile
Scopus Coverage:2015-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.271

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
12

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
0.66

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations118
3-Year Documents173
Citable Documents136

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ3
Endocrinology, Diabetes and MetabolismQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica
Publication Language
English, Polish
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ENDOCRINOLOGY & METABOLISM
JCRESCI
177/198Q4
ENDOCRINOLOGY & METABOLISM
JCIESCI
178/198Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
20250.766,961670
20240.799,5101,114
20230.757,5021,326
2022—35,1411,454
2021—23,3862,578
2020—17,7042,639
2019—14,3222,017
2018—13,4961,706
2017—13,1291,537
2016—11,4981,204
2015—10,9001,031
2014—8,591859
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Clinical Diabetology

WoS Q4
00112023202420250.70
Annual Impact Factor Metric
2025:0.7

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e9560a4d-4483-4620-8b88-1681c611865a
Database Updated: 2026-10-01